TAGNEY

About this trial

The primary objective of the study is to compare the faecal microbiome pre and post ICI treatment to look got biomarkers of positive treatment response.

Patients who are participating in this study will have stool samples collected at 3 time-points.
The first sample at baseline before starting treatment. The second sample is prior to cycle 2 or 2-4 weeks after the baseline sample. Finally, at approximately 3 months from baseline visit.
These samples will be collected by the patient at home with kits provided by the study. Once the sample is collected the patient will post it directly to the laboratory using the provided paid postage envelopes.

Patient Profile

Patients with metastatic or unresectable solid tumour who are eligible to receive Immune Checkpoint Inhibitor’s(ICI’s) alone or in combination with chemotherapy.

Patients previously treated with ICI’s are not eligible.

Where’s this trial being run?

Bon Secours Cork

Can I join this study / trial?

The first step we recommend is to talk to your doctor or the cancer trials team at your hospital. You can find contact details for cancer trials research units in Ireland here.

It’s also a good idea to print this page and bring it with you to your appointment. It can help guide the conversation and remind you of what to ask. You may also want to talk to your family or friends about your options, as they can offer support as you make decisions.

For more detailed information

Click Here

Questions?

Here’s a list of questions you may have for your doctor or local cancer research team.

Questions

---

Summary Data

Name:	TAGNEY
Number:	24-19
Full Title:	The Tangney Study: Microbiome Biomarker Prediction of Response to Cancer Therapies

Principal Investigator:	Dr Brian Bird
Type:	Collaborative
Sponsor:	Cork University Hospital
Recruitment Started:	Global: Ireland:

Global Recruitment Target:
Ireland Recruitment Target: